迪瑞医疗收盘下跌1.12%，滚动市盈率101.31倍，总市值36.27亿元

Core Viewpoint - The company, Dirui Medical, is experiencing significant financial challenges, with a high price-to-earnings (PE) ratio compared to its industry peers, indicating potential overvaluation in the current market [1][2]. Company Summary - Dirui Medical's stock closed at 13.3 yuan, down 1.12%, with a rolling PE ratio of 101.31 times and a total market capitalization of 3.627 billion yuan [1]. - The company operates in the medical device sector, focusing on the research, production, marketing, and service of medical testing instruments and related reagents [1]. - Dirui Medical has a total of 213 patents, including 136 invention patents and 96 software copyrights [1]. Financial Performance - In the first quarter of 2025, Dirui Medical reported revenue of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.68 million yuan, down 87.13% year-on-year, with a gross profit margin of 42.78% [1]. Industry Comparison - The average PE ratio for the medical device industry is 48.71 times, with a median of 35.37 times, placing Dirui Medical at the 107th position in the industry ranking [1][2]. - The company has seen a net inflow of 2.36 million yuan in principal funds on May 22, but has experienced an overall outflow of 5.21 million yuan over the past five days [1].